← Open Payments lookup

CASSANDRA VEALE: Open Payments

NPI 1740996495 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,472 in 74 payments from 14 companies in 2025. Trend: 2023 $1,645 · 2024 $1,857 · 2025 $1,472

Food & beverage: $1,472
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.14$349
Vanda Pharmaceuticals Inc.6$201
ABBVIE INC.14$178
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$165
Alkermes, Inc.6$138
E.R. Squibb & Sons, L.L.C.7$115
Janssen Pharmaceuticals, Inc6$104
Neurocrine BioSciences, Inc.3$67
Teva Pharmaceuticals USA, Inc.4$62
Lundbeck LLC1$25

Products named: VRAYLAR, FANAPT, CAPLYTA, REXULTI, ARISTADA, ABILIFY MAINTENA, COBENFY, ABILIFY ASIMTUFII.

Industry payments across MO — which companies pay providers there.